BindingDB logo
myBDB logout

null

SMILES: CN([C@@H]1C[C@@H](C1)NS(C)(=O)=O)c1ncnc2[nH]ccc12

InChI Key: InChIKey=QZOGHNDWZHFIJP-DTORHVGOSA-N

PDB links: 1 PDB ID matches this monomer.

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 50243850   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM50243850
PNG
(CHEMBL4100431)
Show SMILES CN([C@@H]1C[C@@H](C1)NS(C)(=O)=O)c1ncnc2[nH]ccc12 |r,wD:2.1,4.6,(3.77,-11.84,;5.11,-12.61,;6.44,-11.83,;6.83,-10.34,;8.32,-10.73,;7.93,-12.22,;9.65,-9.96,;10.98,-10.72,;12.32,-9.95,;11.74,-12.05,;10.21,-12.04,;5.11,-14.15,;3.78,-14.92,;3.78,-16.46,;5.12,-17.23,;6.46,-16.45,;7.93,-16.92,;8.83,-15.67,;7.91,-14.43,;6.45,-14.91,)|
Show InChI InChI=1S/C12H17N5O2S/c1-17(9-5-8(6-9)16-20(2,18)19)12-10-3-4-13-11(10)14-7-15-12/h3-4,7-9,16H,5-6H2,1-2H3,(H,13,14,15)/t8-,9+
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
PDB
UniChem
Article
PubMed
n/an/a 1.29E+3n/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant human JAK2 using FITC-KGGEEEEYFELVKK as substrate in presence of 1 mM ATP by mobility shift assay


J Med Chem 61: 1130-1152 (2018)


Article DOI: 10.1021/acs.jmedchem.7b01598
BindingDB Entry DOI: 10.7270/Q2D79DTW
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK1


(Homo sapiens (Human))
BDBM50243850
PNG
(CHEMBL4100431)
Show SMILES CN([C@@H]1C[C@@H](C1)NS(C)(=O)=O)c1ncnc2[nH]ccc12 |r,wD:2.1,4.6,(3.77,-11.84,;5.11,-12.61,;6.44,-11.83,;6.83,-10.34,;8.32,-10.73,;7.93,-12.22,;9.65,-9.96,;10.98,-10.72,;12.32,-9.95,;11.74,-12.05,;10.21,-12.04,;5.11,-14.15,;3.78,-14.92,;3.78,-16.46,;5.12,-17.23,;6.46,-16.45,;7.93,-16.92,;8.83,-15.67,;7.91,-14.43,;6.45,-14.91,)|
Show InChI InChI=1S/C12H17N5O2S/c1-17(9-5-8(6-9)16-20(2,18)19)12-10-3-4-13-11(10)14-7-15-12/h3-4,7-9,16H,5-6H2,1-2H3,(H,13,14,15)/t8-,9+
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
PDB
UniChem
PDB
Article
PubMed
n/an/a 90n/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant human JAK1 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay


J Med Chem 61: 1130-1152 (2018)


Article DOI: 10.1021/acs.jmedchem.7b01598
BindingDB Entry DOI: 10.7270/Q2D79DTW
More data for this
Ligand-Target Pair
3D
3D Structure (crystal)
Non-receptor tyrosine-protein kinase TYK2


(Homo sapiens (Human))
BDBM50243850
PNG
(CHEMBL4100431)
Show SMILES CN([C@@H]1C[C@@H](C1)NS(C)(=O)=O)c1ncnc2[nH]ccc12 |r,wD:2.1,4.6,(3.77,-11.84,;5.11,-12.61,;6.44,-11.83,;6.83,-10.34,;8.32,-10.73,;7.93,-12.22,;9.65,-9.96,;10.98,-10.72,;12.32,-9.95,;11.74,-12.05,;10.21,-12.04,;5.11,-14.15,;3.78,-14.92,;3.78,-16.46,;5.12,-17.23,;6.46,-16.45,;7.93,-16.92,;8.83,-15.67,;7.91,-14.43,;6.45,-14.91,)|
Show InChI InChI=1S/C12H17N5O2S/c1-17(9-5-8(6-9)16-20(2,18)19)12-10-3-4-13-11(10)14-7-15-12/h3-4,7-9,16H,5-6H2,1-2H3,(H,13,14,15)/t8-,9+
PDB

KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
PDB
UniChem
Article
PubMed
n/an/a>2.00E+5n/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of recombinant human TYK2 using 5'FAM-KKSRGDYMTMQID as substrate in presence of 1 mM ATP by mobility shift assay


J Med Chem 61: 1130-1152 (2018)


Article DOI: 10.1021/acs.jmedchem.7b01598
BindingDB Entry DOI: 10.7270/Q2D79DTW
More data for this
Ligand-Target Pair
Non-receptor tyrosine-protein kinase TYK2/Tyrosine-protein kinase JAK1


(Homo sapiens (Human))
BDBM50243850
PNG
(CHEMBL4100431)
Show SMILES CN([C@@H]1C[C@@H](C1)NS(C)(=O)=O)c1ncnc2[nH]ccc12 |r,wD:2.1,4.6,(3.77,-11.84,;5.11,-12.61,;6.44,-11.83,;6.83,-10.34,;8.32,-10.73,;7.93,-12.22,;9.65,-9.96,;10.98,-10.72,;12.32,-9.95,;11.74,-12.05,;10.21,-12.04,;5.11,-14.15,;3.78,-14.92,;3.78,-16.46,;5.12,-17.23,;6.46,-16.45,;7.93,-16.92,;8.83,-15.67,;7.91,-14.43,;6.45,-14.91,)|
Show InChI InChI=1S/C12H17N5O2S/c1-17(9-5-8(6-9)16-20(2,18)19)12-10-3-4-13-11(10)14-7-15-12/h3-4,7-9,16H,5-6H2,1-2H3,(H,13,14,15)/t8-,9+
PDB

UniProtKB/SwissProt

antibodypedia
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
PDB
UniChem
PDB
Article
PubMed
n/an/a 750n/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of JAK1/TYK2 in human whole blood assessed as reduction in IFNalpha induced STAT3 phosphorylation preincubated for 45 mins followed by IFN...


J Med Chem 61: 1130-1152 (2018)


Article DOI: 10.1021/acs.jmedchem.7b01598
BindingDB Entry DOI: 10.7270/Q2D79DTW
More data for this
Ligand-Target Pair
3D
3D Structure (crystal)
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM50243850
PNG
(CHEMBL4100431)
Show SMILES CN([C@@H]1C[C@@H](C1)NS(C)(=O)=O)c1ncnc2[nH]ccc12 |r,wD:2.1,4.6,(3.77,-11.84,;5.11,-12.61,;6.44,-11.83,;6.83,-10.34,;8.32,-10.73,;7.93,-12.22,;9.65,-9.96,;10.98,-10.72,;12.32,-9.95,;11.74,-12.05,;10.21,-12.04,;5.11,-14.15,;3.78,-14.92,;3.78,-16.46,;5.12,-17.23,;6.46,-16.45,;7.93,-16.92,;8.83,-15.67,;7.91,-14.43,;6.45,-14.91,)|
Show InChI InChI=1S/C12H17N5O2S/c1-17(9-5-8(6-9)16-20(2,18)19)12-10-3-4-13-11(10)14-7-15-12/h3-4,7-9,16H,5-6H2,1-2H3,(H,13,14,15)/t8-,9+
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
PDB
UniChem
Article
PubMed
n/an/a 1.19E+4n/an/an/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Inhibition of JAK2 in CD34+ human whole blood assessed as reduction in EOP induced STAT5 phosphorylation preincubated for 45 mins followed by EOP add...


J Med Chem 61: 1130-1152 (2018)


Article DOI: 10.1021/acs.jmedchem.7b01598
BindingDB Entry DOI: 10.7270/Q2D79DTW
More data for this
Ligand-Target Pair